The NTIS website and supporting ordering systems are undergoing a major upgrade from 8PM on September 25th through approximately October 6. During that time, much of the functionality, including subscription and product ordering, shipping, etc., will not be available. You may call NTIS at 1-800-553-6847 or (703) 605-6000 to place an order but you should expect delayed shipment. Please do NOT include credit card numbers in any email you might send NTIS.
Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website; (3) the federal government Internet portal; or (4) a web search conducted using a commercial search engine such as
Accession Number ADA575372
Title Development of Practical and Rapid Field-Based Therapies for SCI.
Publication Date Oct 2012
Media Count 6p
Personal Author J. H. Brock M. Tuszynski
Abstract There is a great unmet medical need to develop effective neuroprotective or regenerative therapies for spinal cord injury. Advances in military medicine establish potential opportunities for tailoring interventions for spinal cord injury to the battlefield, where the possibility exist for very early administration of therapeutic substances, followed by more extensive and specialized treatment rendered at a secondary care facility to which SCI victims might be transferred 12-72 hours following an injury. Our proposal is examining whether implantation of allogenic bone marrow stromal cell grafts (BMSCs) into spinal cord lesion site will improve behavior and anatomical outcomes after spinal cord contusion. The BMSCs are genetically engineered to secrete growth factors that we hypothesize will reduce cell lose at the injury site and recruit neuroprotective Schwann cells to lesion site to reduce secondary cell loss cavitation. Positive results of this research could lead to clinical trials.
Keywords Behavior
Regenerative medicine
Spinal cord
Wounds and injuries

Source Agency Non Paid ADAS
NTIS Subject Category 57E - Clinical Medicine
Corporate Author California Univ., San Diego, La Jolla.
Document Type Technical report
Title Note Annual rept. 30 Sep 2011-29 Sep 2012.
NTIS Issue Number 1319
Contract Number W81XWH-10-1-0869

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader